AltweinJ. E., JacobiG. H.: Hormonotherapic des Prostata Karzinoms. Urologe A., 19; 350 (1980).
2.
BensonR. C., WearJ. B., GillG. M.: Treatment of stage D hormone-resistent carcinoma of the prostate with estramustine phosphate. J. Urol., 121; 452 (1979).
3.
FritjonfssonA., NorlenB. J., HogbergB.: Hormonal effects of different doses of estramustine phosphate (Estracyt) in patients with prostatic carcinoma. Gosta Jonsson in memoriam. Scand, J. Urol. & Nephrol., 15; 37 (1981).
4.
FurnariS., PavoneM.: Terapia antiblastica nei tumori prostatici. Atti XLIII Congr. S.I.U., pag. 307, Firenze 1970.
5.
GustafssonA., NilssonS., PerssonB.: Treatment with oral estramustine phosphate (Estracyt) in prostatic carcinoma. Influence on lipid and carboydrate metabolism. Invest. Urol., 15; 220 (1977).
JonssonG.: Cytotoxis agents in the treatment of prostatic carcinoma. International Symposium on the treatment of carcinoma of the prostate, p. 145. Pergamon Press, Berlin1969.
8.
JonssonG., HogbergB., NilssonF.: Treatment of advanced prostatic carcinoma with estramustine phosphate (Estracyt). Scand. J. Urol. & Nephrol., 11, 231 (1977).
9.
KadohamaN., KirdaniR. Y., MadajewiczS.: Estramustine phosphate. Metabolism pattern and possible mechanism for its action in prostate cancer. N.Y. State J. Med., 79; 1005 (1979).
10.
KadohamaN., KirdaniR. Y., MurphyG. P., SandbergA. A.: Estramustine phosphate: metabolic aspects related to its action in prostatic cancer. J. Urol., 119; 235 (1978).
11.
KussR., KhouryS., RichardF.: Estramustine phosphate in the treatment of advanced prostatic carcinoma. Brit. J. Urol., 52; 29 (1980).
12.
MurphyG. P., GibbonsR. P., JohnsonD. E.: The use of estramustine and prednimustine versus prednimustine alone in advanced metastatic prostatic cancer in patients who have received prior irradiation. J. Urol., 121; 763 (1979).
13.
NagelR., KoellnC. P.: Treatment of advanced carcinoma of the prostate with estramustine phosphate. Brit. J. Urol., 49; 73 (1977).